glp-1 truth serum is the podcast where I talk about the parts of the GLP-1 conversation that make people uncomfortable. Hosted by Virgie Tovar—a longtime voice on weight stigma—this show asks Virgie - Meet Virgie and
Description
This article examines the current evidence regarding any potential relationship between GLP-1 therapy and cortisol regulation, clarifying what these medications can and cannot achieve within UK clinical practice
Great facility! Scott S

Each animal was identified by an implantable microchip (PetID Microchip, E-vet, Haderslev, Denmark)
Unlike many weight loss supplements, this stack takes a holistic approach, addressing hunger control, metabolism, gut health, and sleep
Of those 161 patients, 16 (10%) experienced recurrent acute pancreatitis after GLP-1 receptor agonist therapy (mean duration 10.8 7.2 months): 6 (38%) were caused by the GLP-1 receptor agonist (as clinically determined by the treating medical team), three (18%) were due to hypertriglyceridemia, two (12%) due to alcohol use, one (6%) due to another oral hypoglycemic agent, one (6%) due to ampulla stenosis, and three (19%) were idiopathic

10.1093/eurheartj/ehae666.442 82
